dehydroepiandrosterone has been researched along with Inflammation in 78 studies
Dehydroepiandrosterone: A major C19 steroid produced by the ADRENAL CORTEX. It is also produced in small quantities in the TESTIS and the OVARY. Dehydroepiandrosterone (DHEA) can be converted to TESTOSTERONE; ANDROSTENEDIONE; ESTRADIOL; and ESTRONE. Most of DHEA is sulfated (DEHYDROEPIANDROSTERONE SULFATE) before secretion.
dehydroepiandrosterone : An androstanoid that is androst-5-ene substituted by a beta-hydroxy group at position 3 and an oxo group at position 17. It is a naturally occurring steroid hormone produced by the adrenal glands.
Inflammation: A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Previous studies have shown that chronic inflammation and oxidative stress may play an important role in the pathophysiology of polycystic ovary syndrome (PCOS), and glutamine (Gln) have showed the anti-inflammatory and antioxidant properties." | 9.34 | The effect of glutamine on Dehydroepiandrosterone-induced polycystic ovary syndrome rats. ( Ding, J; Hu, X; Wu, G; Yang, J, 2020) |
| "This study was implemented to address the role of Roflumilast in polycystic ovary syndrome (PCOS) as well as to discuss its reaction mechanism in vivo and in vitro." | 8.31 | PDE4 inhibitor Roflumilast modulates inflammation and lipid accumulation in PCOS mice to improve ovarian function and reduce DHEA-induced granulosa cell apoptosis in vitro. ( Dong, X; Ji, X; Liu, S; Wang, L; Ye, Y, 2023) |
| "Although nerolidol (NRL) is a naturally occurring sesquiterpene alcohol with many pharmacological activities, its role in dehydroepiandrosterone DHEA-induced polycystic ovary syndrome PCOS is unknown." | 8.31 | Nerolidol attenuates dehydroepiandrosterone-induced polycystic ovary syndrome in rats by regulating oxidative stress and decreasing apoptosis. ( Aydın, M; Çiftçi, O; Doğan, A; Hayal, TB; Özek, DA; Taşlıdere, A; Türkmen, NB; Ünüvar, S; Yaşar, Ş; Yüce, H, 2023) |
| " The present research explores potentially advantageous BHF impacts and whereby BHF alleviates dehydroepiandrosterone (DHEA)-induced inflammation and endocrine disruption." | 8.12 | Inhibitory effect of bushen huoxue formula against dehydroepiandrosterone-induced inflammation in granulosa cells through TLR4/NF-κB signaling pathway. ( Chen, X; Cui, M; Fu, B; Jin, W; Sun, L; Wang, C; Wang, M, 2022) |
| "Administration of dehydroepiandrosterone (DHEA) has been demonstrated to improve survival and cellular immune functions during systemic inflammation." | 7.76 | Dehydroepiandrosterone modulates survival and immune functions during sepsis depending on the way of drug administration. ( Hammes, F; Kobbe, P; Oberbeck, R; Schmitz, D; Wegner, A, 2010) |
| "Dehydroepiandrosterone (DHEA) has beneficial effects in fat-reduction, anti-oxidation and anti-inflammation, and it was widely applied to alleviate multiple metabolic-related diseases; however, there are few reports on whether DHEA can prevent against metabolic-related diseases by modulating oxidative stress and inflammation, especially FLHS in laying hens." | 5.91 | Dehydroepiandrosterone protects against oleic acid-triggered mitochondrial dysfunction to relieve oxidative stress and inflammation via activation of the AMPK-Nrf2 axis by targeting GPR30 in hepatocytes. ( Jiang, Z; Ma, H; Wang, H; Yang, Y; Yao, Y, 2023) |
| "Inflammation is involved in the progression of polycystic ovary syndrome." | 5.91 | Glucagon-like peptide-1 receptor agonists decrease hyperinsulinemia and hyperandrogenemia in dehydroepiandrosterone-induced polycystic ovary syndrome mice and are associated with mitigating inflammation and inducing browning of white adipose tissue†. ( Ding, X; Li, G; Li, N; Lin, Y; Ma, Y; Wang, X; Xiong, C; Yang, Y; Yuan, Y; Zhang, Y; Zhang, Z, 2023) |
| "Inflammation is likely to be a crucial contributor to the pathogenesis of PCOS." | 5.51 | Dehydroepiandrosterone stimulates inflammation and impairs ovarian functions of polycystic ovary syndrome. ( Bulbul, A; Chen, S; Cui, X; Li, Y; Liu, S; Sun, D; Yan, Q; Zheng, Q, 2019) |
| "The risk for atherosclerosis is increased in postmenopausal women." | 5.37 | Protective effects of dehydroepiandrosterone on atherosclerosis in ovariectomized rabbits via alleviating inflammatory injury in endothelial cells. ( Hao, Q; Li, DJ; Wang, L; Wang, WJ; Wang, YD, 2011) |
| "Previous studies have shown that chronic inflammation and oxidative stress may play an important role in the pathophysiology of polycystic ovary syndrome (PCOS), and glutamine (Gln) have showed the anti-inflammatory and antioxidant properties." | 5.34 | The effect of glutamine on Dehydroepiandrosterone-induced polycystic ovary syndrome rats. ( Ding, J; Hu, X; Wu, G; Yang, J, 2020) |
| "Dehydroepiandrosterone (DHEA) was converted into androstenediol, androstenedione (ASD), 16alphaOH-DHEA, 7alphaOH-DHEA, testosterone, estrone (E1), estradiol (E2), estriol (E3), and 16alphaOH-testosterone (similar in OA and RA)." | 5.33 | Androgen conversion in osteoarthritis and rheumatoid arthritis synoviocytes--androstenedione and testosterone inhibit estrogen formation and favor production of more potent 5alpha-reduced androgens. ( Anders, S; Naumann, H; Schmidt, M; Schölmerich, J; Straub, RH; Weidler, C, 2005) |
| "Airway inflammation was provoked in D." | 5.31 | Dehydroepiandrosterone attenuates allergic airway inflammation in Dermatophagoides farinae-sensitized mice. ( Chen, CL; Liu, YH; Yu, CK, 2002) |
| "The molar ratio of serum levels of DHEA/androstenedione (ASD) was increased in patients with an acute inflammatory stressful disease state and was decreased in patients with chronic inflammation." | 5.10 | Dehydroepiandrosterone in relation to other adrenal hormones during an acute inflammatory stressful disease state compared with chronic inflammatory disease: role of interleukin-6 and tumour necrosis factor. ( Falk, W; Herfarth, H; Lehle, K; Preuner, J; Scholmerich, J; Straub, RH; Weber, M, 2002) |
| "This study was implemented to address the role of Roflumilast in polycystic ovary syndrome (PCOS) as well as to discuss its reaction mechanism in vivo and in vitro." | 4.31 | PDE4 inhibitor Roflumilast modulates inflammation and lipid accumulation in PCOS mice to improve ovarian function and reduce DHEA-induced granulosa cell apoptosis in vitro. ( Dong, X; Ji, X; Liu, S; Wang, L; Ye, Y, 2023) |
| "Although nerolidol (NRL) is a naturally occurring sesquiterpene alcohol with many pharmacological activities, its role in dehydroepiandrosterone DHEA-induced polycystic ovary syndrome PCOS is unknown." | 4.31 | Nerolidol attenuates dehydroepiandrosterone-induced polycystic ovary syndrome in rats by regulating oxidative stress and decreasing apoptosis. ( Aydın, M; Çiftçi, O; Doğan, A; Hayal, TB; Özek, DA; Taşlıdere, A; Türkmen, NB; Ünüvar, S; Yaşar, Ş; Yüce, H, 2023) |
| " Biomarkers of intestinal permeability (liposaccharide-binding protein [LBP]) and BBB permeability (S100 calcium-binding protein B [S100B]), stress (cortisol, dehydroepiandrosterone sulfate [DHEA-S] epinephrine, norepinephrine) and inflammation (interleukin-6 [IL-6], high-sensitivity C-reactive protein [hsCRP]) were measured in blood." | 4.12 | Stress and the gut-brain axis: Cognitive performance, mood state, and biomarkers of blood-brain barrier and intestinal permeability following severe physical and psychological stress. ( Berryman, CE; Farina, EK; Halagarda, CJ; Lieberman, HR; McClung, HL; McClung, JP; Pasiakos, SM; Philip Karl, J; Sepowitz, JJ; Varanoske, AN, 2022) |
| " The present research explores potentially advantageous BHF impacts and whereby BHF alleviates dehydroepiandrosterone (DHEA)-induced inflammation and endocrine disruption." | 4.12 | Inhibitory effect of bushen huoxue formula against dehydroepiandrosterone-induced inflammation in granulosa cells through TLR4/NF-κB signaling pathway. ( Chen, X; Cui, M; Fu, B; Jin, W; Sun, L; Wang, C; Wang, M, 2022) |
| "Administration of dehydroepiandrosterone (DHEA) has been demonstrated to improve survival and cellular immune functions during systemic inflammation." | 3.76 | Dehydroepiandrosterone modulates survival and immune functions during sepsis depending on the way of drug administration. ( Hammes, F; Kobbe, P; Oberbeck, R; Schmitz, D; Wegner, A, 2010) |
| "Vaginitis is one of the most common causes of patient visits to gynecologists, primary care providers, and urgent care centers." | 2.66 | Noncandidal vaginitis: a comprehensive approach to diagnosis and management. ( Eckert, LO; Kus, LH; Neal, CM; Peipert, JF, 2020) |
| "Dehydroepiandrosterone (DHEA) is a multifunctional steroid with a broad range of biological effects in humans and animals." | 2.48 | Oxidative metabolism of dehydroepiandrosterone (DHEA) and biologically active oxygenated metabolites of DHEA and epiandrosterone (EpiA)--recent reports. ( El Kihel, L, 2012) |
| "Dehydroepiandrosterone (DHEA) has beneficial effects in fat-reduction, anti-oxidation and anti-inflammation, and it was widely applied to alleviate multiple metabolic-related diseases; however, there are few reports on whether DHEA can prevent against metabolic-related diseases by modulating oxidative stress and inflammation, especially FLHS in laying hens." | 1.91 | Dehydroepiandrosterone protects against oleic acid-triggered mitochondrial dysfunction to relieve oxidative stress and inflammation via activation of the AMPK-Nrf2 axis by targeting GPR30 in hepatocytes. ( Jiang, Z; Ma, H; Wang, H; Yang, Y; Yao, Y, 2023) |
| "Inflammation is involved in the progression of polycystic ovary syndrome." | 1.91 | Glucagon-like peptide-1 receptor agonists decrease hyperinsulinemia and hyperandrogenemia in dehydroepiandrosterone-induced polycystic ovary syndrome mice and are associated with mitigating inflammation and inducing browning of white adipose tissue†. ( Ding, X; Li, G; Li, N; Lin, Y; Ma, Y; Wang, X; Xiong, C; Yang, Y; Yuan, Y; Zhang, Y; Zhang, Z, 2023) |
| "Endometritis is persistent inflammation caused by bacteria, which can lead to infertility." | 1.72 | Baogong decoction treats endometritis in mice by regulating uterine microbiota structure and metabolites. ( Ding, H; Li, Q; Li, Z; Liu, H; Lu, W; Wang, J; Wang, Y; Zhao, J, 2022) |
| "Inflammation is likely to be a crucial contributor to the pathogenesis of PCOS." | 1.51 | Dehydroepiandrosterone stimulates inflammation and impairs ovarian functions of polycystic ovary syndrome. ( Bulbul, A; Chen, S; Cui, X; Li, Y; Liu, S; Sun, D; Yan, Q; Zheng, Q, 2019) |
| "Dehydroepiandrosterone (DHEA) has anti-inflammatory, anti-oxidant and immune-regulating properties, while the mechanism of DHEA actions remains unclear." | 1.51 | Effect of dehydroepiandrosterone on the immune function of mice in vivo and in vitro. ( Cao, J; Ma, H; Yu, L; Zhao, J, 2019) |
| "Dehydroepiandrosterone (DHEA) has been shown to have immunomodulatory effects after hemorrhage and sepsis." | 1.40 | Dehydroepiandrosterone modulates the inflammatory response in a bilateral femoral shaft fracture model. ( Ewers, P; Hildebrand, F; Kobbe, P; Lichte, P; Pape, HC; Pfeifer, R; Pufe, T; Tohidnezhad, M; Werner, BE, 2014) |
| "The risk for atherosclerosis is increased in postmenopausal women." | 1.37 | Protective effects of dehydroepiandrosterone on atherosclerosis in ovariectomized rabbits via alleviating inflammatory injury in endothelial cells. ( Hao, Q; Li, DJ; Wang, L; Wang, WJ; Wang, YD, 2011) |
| "Dehydroepiandrosterone (DHEA) was converted into androstenediol, androstenedione (ASD), 16alphaOH-DHEA, 7alphaOH-DHEA, testosterone, estrone (E1), estradiol (E2), estriol (E3), and 16alphaOH-testosterone (similar in OA and RA)." | 1.33 | Androgen conversion in osteoarthritis and rheumatoid arthritis synoviocytes--androstenedione and testosterone inhibit estrogen formation and favor production of more potent 5alpha-reduced androgens. ( Anders, S; Naumann, H; Schmidt, M; Schölmerich, J; Straub, RH; Weidler, C, 2005) |
| "Airway inflammation was provoked in D." | 1.31 | Dehydroepiandrosterone attenuates allergic airway inflammation in Dermatophagoides farinae-sensitized mice. ( Chen, CL; Liu, YH; Yu, CK, 2002) |
| "The etiology of rheumatoid arthritis has been elusive, but it finally seems to be explained by a combination of three factors: (i) a relatively mild deficiency of cortisol, the normal adrenocortical hormone that is essential for normal immunity but which has achieved a bad reputation because of the use of excessive dosages of it or its stronger derivatives, (ii) a deficiency of dehydro-epi-androsterone (DHEA), the chief androgen produced by the human adrenal cortex but which has been little studied, and (iii) infection by organisms such as mycoplasma, which have a relatively low virulence, are difficult to culture in the laboratory, and cause inflammation and destruction of tissue in periarticular and articular areas of immunocompromised hosts." | 1.30 | The etiology of rheumatoid arthritis. ( Jefferies, WM, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (7.69) | 18.7374 |
| 1990's | 3 (3.85) | 18.2507 |
| 2000's | 19 (24.36) | 29.6817 |
| 2010's | 30 (38.46) | 24.3611 |
| 2020's | 20 (25.64) | 2.80 |
| Authors | Studies |
|---|---|
| Saunders, MJ | 1 |
| Edwards, BS | 1 |
| Zhu, J | 1 |
| Sklar, LA | 1 |
| Graves, SW | 1 |
| Yang, YX | 1 |
| Zheng, LT | 1 |
| Shi, JJ | 1 |
| Gao, B | 1 |
| Chen, YK | 1 |
| Yang, HC | 1 |
| Chen, HL | 1 |
| Li, YC | 1 |
| Zhen, XC | 1 |
| Koperniku, A | 1 |
| Garcia, AA | 1 |
| Mochly-Rosen, D | 1 |
| Varanoske, AN | 1 |
| McClung, HL | 1 |
| Sepowitz, JJ | 1 |
| Halagarda, CJ | 1 |
| Farina, EK | 1 |
| Berryman, CE | 1 |
| Lieberman, HR | 1 |
| McClung, JP | 1 |
| Pasiakos, SM | 1 |
| Philip Karl, J | 1 |
| Ullah, A | 1 |
| Wang, MJ | 1 |
| Yang, JP | 1 |
| Adu-Gyamfi, EA | 1 |
| Czika, A | 1 |
| Sah, SK | 1 |
| Feng, Q | 1 |
| Wang, YX | 1 |
| Jin, W | 1 |
| Wang, C | 1 |
| Cui, M | 1 |
| Wang, M | 1 |
| Fu, B | 1 |
| Sun, L | 1 |
| Chen, X | 1 |
| Ding, H | 2 |
| Wang, Y | 11 |
| Li, Z | 1 |
| Li, Q | 2 |
| Liu, H | 1 |
| Zhao, J | 4 |
| Lu, W | 1 |
| Wang, J | 1 |
| Xia, J | 1 |
| Wu, S | 1 |
| Wu, G | 2 |
| Yang, J | 5 |
| Chen, Y | 3 |
| Kuang, H | 3 |
| Feng, X | 3 |
| Ji, X | 1 |
| Ye, Y | 1 |
| Wang, L | 2 |
| Liu, S | 3 |
| Dong, X | 2 |
| Türkmen, NB | 1 |
| Yüce, H | 1 |
| Aydın, M | 1 |
| Taşlıdere, A | 1 |
| Doğan, A | 1 |
| Özek, DA | 1 |
| Hayal, TB | 1 |
| Yaşar, Ş | 1 |
| Çiftçi, O | 1 |
| Ünüvar, S | 1 |
| Yao, Q | 1 |
| Li, X | 2 |
| Wu, H | 2 |
| Sun, C | 1 |
| Bai, W | 1 |
| Kang, J | 1 |
| Yao, Y | 2 |
| Wang, H | 4 |
| Yang, Y | 2 |
| Jiang, Z | 1 |
| Ma, H | 5 |
| Zhang, Y | 2 |
| Lin, Y | 1 |
| Li, G | 1 |
| Yuan, Y | 1 |
| Wang, X | 1 |
| Li, N | 1 |
| Xiong, C | 1 |
| Ma, Y | 1 |
| Zhang, Z | 1 |
| Ding, X | 1 |
| Weng, Y | 1 |
| Wang, D | 1 |
| Wang, R | 1 |
| Xiang, Z | 1 |
| Shen, S | 1 |
| Wu, X | 1 |
| Wen, Y | 1 |
| Xiang, Y | 1 |
| Xu, T | 1 |
| Liu, X | 1 |
| Huang, Z | 1 |
| Ge, H | 1 |
| Neal, CM | 1 |
| Kus, LH | 1 |
| Eckert, LO | 1 |
| Peipert, JF | 1 |
| Cao, J | 4 |
| Yu, L | 3 |
| Hu, X | 1 |
| Ding, J | 1 |
| D Prabhu, Y | 1 |
| Valsala Gopalakrishnan, A | 1 |
| Scarola, SJ | 1 |
| Bardi, M | 1 |
| Shen, X | 1 |
| Li, L | 1 |
| Chen, CY | 1 |
| Liao, YH | 1 |
| Chou, CC | 1 |
| Sung, YC | 1 |
| Tsai, SC | 1 |
| Alexaki, VI | 1 |
| Fodelianaki, G | 1 |
| Neuwirth, A | 1 |
| Mund, C | 1 |
| Kourgiantaki, A | 1 |
| Ieronimaki, E | 1 |
| Lyroni, K | 1 |
| Troullinaki, M | 1 |
| Fujii, C | 1 |
| Kanczkowski, W | 1 |
| Ziogas, A | 1 |
| Peitzsch, M | 1 |
| Grossklaus, S | 1 |
| Sönnichsen, B | 1 |
| Gravanis, A | 1 |
| Bornstein, SR | 2 |
| Charalampopoulos, I | 1 |
| Tsatsanis, C | 1 |
| Chavakis, T | 1 |
| Maciel-Barón, LÁ | 1 |
| Morales-Rosales, SL | 1 |
| Silva-Palacios, A | 1 |
| Rodríguez-Barrera, RH | 1 |
| García-Álvarez, JA | 1 |
| Luna-López, A | 1 |
| Pérez, VI | 1 |
| Torres, C | 1 |
| Königsberg, M | 1 |
| Collomp, K | 1 |
| Gravisse, N | 1 |
| Vibarel-Rebot, N | 1 |
| Asselin, M | 1 |
| Do, MC | 1 |
| Gagey, O | 1 |
| Le-Tiec, C | 1 |
| Dufay, S | 1 |
| Buisson, C | 1 |
| Audran, M | 1 |
| Li, Y | 1 |
| Zheng, Q | 1 |
| Sun, D | 1 |
| Cui, X | 1 |
| Chen, S | 1 |
| Bulbul, A | 1 |
| Yan, Q | 1 |
| Xue, J | 1 |
| Liu, P | 1 |
| Li, K | 1 |
| Sha, L | 1 |
| Yang, X | 1 |
| Zhu, L | 1 |
| Wang, Z | 1 |
| Dong, Y | 1 |
| Zhang, L | 1 |
| Lei, H | 1 |
| Zhang, X | 1 |
| Huerta-García, E | 1 |
| Montiél-Dávalos, A | 1 |
| Alfaro-Moreno, E | 1 |
| Gutiérrez-Iglesias, G | 1 |
| López-Marure, R | 1 |
| Reading, CL | 3 |
| Stickney, DR | 1 |
| Flores-Riveros, J | 2 |
| Destiche, DA | 1 |
| Ahlem, CN | 1 |
| Cefalu, WT | 1 |
| Frincke, JM | 4 |
| Chan, CC | 1 |
| Liou, CJ | 1 |
| Xu, PY | 1 |
| Shen, JJ | 1 |
| Kuo, ML | 1 |
| Len, WB | 1 |
| Chang, LE | 1 |
| Huang, WC | 1 |
| Chen, J | 1 |
| Xu, L | 1 |
| Huang, C | 1 |
| González, F | 2 |
| Sia, CL | 1 |
| Bearson, DM | 2 |
| Blair, HE | 2 |
| Lichte, P | 1 |
| Pfeifer, R | 1 |
| Werner, BE | 1 |
| Ewers, P | 1 |
| Tohidnezhad, M | 1 |
| Pufe, T | 1 |
| Hildebrand, F | 1 |
| Pape, HC | 1 |
| Kobbe, P | 2 |
| Sreekumaran Nair, K | 1 |
| Basal, E | 1 |
| Schimke, JM | 1 |
| Lettieri-Barbato, D | 1 |
| Giovannetti, E | 1 |
| Aquilano, K | 1 |
| Boström, EA | 1 |
| d'Elia, HF | 1 |
| Dahlgren, U | 1 |
| Simark-Mattsson, C | 1 |
| Hasséus, B | 1 |
| Carlsten, H | 1 |
| Tarkowski, A | 1 |
| Bokarewa, M | 1 |
| Bauer, ME | 1 |
| Pérez, AR | 1 |
| Bottasso, O | 2 |
| Savino, W | 1 |
| Lu, M | 1 |
| Patsouris, D | 1 |
| Li, P | 1 |
| Watkins, S | 1 |
| Schenk, S | 1 |
| Olefsky, JM | 1 |
| Pugh, ME | 1 |
| Hemnes, AR | 1 |
| Thierer, J | 1 |
| Acosta, A | 1 |
| Vainstein, N | 1 |
| Sultan, M | 1 |
| Francesia, A | 1 |
| Marino, J | 1 |
| Prado, AH | 1 |
| Guglielmone, R | 1 |
| Trivi, M | 1 |
| Boero, L | 1 |
| Brites, F | 1 |
| Anker, S | 1 |
| Schmitz, D | 1 |
| Wegner, A | 1 |
| Hammes, F | 1 |
| Oberbeck, R | 1 |
| Hao, Q | 1 |
| Wang, YD | 1 |
| Wang, WJ | 1 |
| Li, DJ | 1 |
| Pizza, V | 1 |
| Agresta, A | 1 |
| D'Acunto, CW | 1 |
| Festa, M | 1 |
| Capasso, A | 1 |
| Kosiewicz, MM | 1 |
| Auci, DL | 1 |
| Fagone, P | 1 |
| Mangano, K | 1 |
| Caponnetto, S | 1 |
| Tucker, CF | 1 |
| Azeem, N | 1 |
| White, SK | 2 |
| Nicoletti, F | 1 |
| Weiss, EP | 1 |
| Villareal, DT | 1 |
| Fontana, L | 1 |
| Han, DH | 1 |
| Holloszy, JO | 1 |
| Traish, AM | 1 |
| Kang, HP | 1 |
| Saad, F | 1 |
| Guay, AT | 1 |
| El Kihel, L | 1 |
| Bay, ML | 1 |
| Besedovsky, H | 1 |
| Del Rey, A | 1 |
| Cutolo, M | 1 |
| Sulli, A | 1 |
| Pizzorni, C | 1 |
| Craviotto, C | 1 |
| Prete, C | 1 |
| Foppiani, L | 1 |
| Salvarani, C | 1 |
| Straub, RH | 4 |
| Seriolo, B | 1 |
| Yu, CK | 1 |
| Liu, YH | 1 |
| Chen, CL | 1 |
| Peña, L | 1 |
| Silván, G | 1 |
| Pérez-Alenza, MD | 1 |
| Nieto, A | 1 |
| Illera, JC | 1 |
| Marx, C | 1 |
| Petros, S | 1 |
| Weise, M | 1 |
| Wendt, M | 1 |
| Menschikowski, M | 1 |
| Engelmann, L | 1 |
| Höffken, G | 1 |
| Kirk-Bayley, J | 1 |
| Venn, R | 1 |
| RUBENS-DUVAL, A | 1 |
| VILLIAUMEY, J | 1 |
| Hinson, JP | 1 |
| Brooke, A | 1 |
| Raven, PW | 1 |
| Dillon, JS | 1 |
| Matsuda, A | 1 |
| Furukawa, K | 1 |
| Suzuki, H | 1 |
| Matsutani, T | 1 |
| Tajiri, T | 1 |
| Chaudry, IH | 1 |
| Schmidt, M | 2 |
| Weidler, C | 2 |
| Naumann, H | 2 |
| Anders, S | 2 |
| Schölmerich, J | 2 |
| Schellenberg, M | 1 |
| Park, J | 1 |
| Choe, SS | 1 |
| Choi, AH | 1 |
| Kim, KH | 1 |
| Yoon, MJ | 1 |
| Suganami, T | 1 |
| Ogawa, Y | 1 |
| Kim, JB | 1 |
| Simm, A | 1 |
| Nass, N | 1 |
| Bartling, B | 1 |
| Hofmann, B | 1 |
| Silber, RE | 1 |
| Navarrete Santos, A | 1 |
| Hennebold, JD | 1 |
| Daynes, RA | 1 |
| Jefferies, WM | 1 |
| Bradlow, HL | 1 |
| Murphy, J | 1 |
| Byrne, JJ | 1 |
| Kanik, KS | 1 |
| Chrousos, GP | 1 |
| Schumacher, HR | 1 |
| Crane, ML | 1 |
| Yarboro, CH | 1 |
| Wilder, RL | 1 |
| Schwartz, AG | 1 |
| Pashko, LL | 1 |
| Leowattana, W | 1 |
| Lehle, K | 1 |
| Herfarth, H | 1 |
| Weber, M | 1 |
| Falk, W | 1 |
| Preuner, J | 1 |
| Harrison, BJ | 1 |
| Kumar, S | 1 |
| Read, GF | 1 |
| Edwards, CA | 1 |
| Scanlon, MF | 1 |
| Hughes, LE | 1 |
| Mortimer, PS | 1 |
| Dawber, RP | 1 |
| Gales, MA | 1 |
| Moore, RA | 1 |
| Pal'chik, DA | 1 |
| Meshcherskaia, KA | 1 |
| Suglobova, VM | 1 |
| Aleksandrov, ID | 1 |
| Efimtseva, AF | 1 |
| Sparagana, M | 1 |
| Phillips, G | 1 |
| Bodel, P | 1 |
| Dillard, GM | 1 |
| Kaplan, SS | 1 |
| Malawista, SE | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Evaluation of the Relationship Between Right Atrial Volume Index, Functional Capacity and Inflammatory Biomarkers in Patients With Chronic Obstructive Lung Disease and Right Heart Affection.[NCT05366400] | 151 participants (Actual) | Observational | 2022-01-19 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
15 reviews available for dehydroepiandrosterone and Inflammation
| Article | Year |
|---|---|
Boosting the Discovery of Small Molecule Inhibitors of Glucose-6-Phosphate Dehydrogenase for the Treatment of Cancer, Infectious Diseases, and Inflammation.
Topics: Communicable Diseases; Drug Discovery; Glucosephosphate Dehydrogenase; High-Throughput Screening Ass | 2022 |
Noncandidal vaginitis: a comprehensive approach to diagnosis and management.
Topics: Administration, Intravaginal; Administration, Oral; Anti-Infective Agents; Anti-Inflammatory Agents; | 2020 |
Effects of dietary restriction on adipose mass and biomarkers of healthy aging in human.
Topics: Adipokines; Adipose Tissue; Aging; Biomarkers; Caloric Restriction; Cytokines; Dehydroepiandrosteron | 2016 |
Chronic stress and immunosenescence: a review.
Topics: Aged; Aged, 80 and over; Aging; Aging, Premature; Caregivers; Chronic Disease; Circadian Rhythm; Cyt | 2008 |
The impact of infectious diseases upon neuroendocrine circuits.
Topics: Animals; Cattle; Communicable Diseases; Cytokines; Dehydroepiandrosterone; Extracellular Matrix Prot | 2009 |
Development of pulmonary arterial hypertension in women: interplay of sex hormones and pulmonary vascular disease.
Topics: Animals; Dehydroepiandrosterone; Disease Models, Animal; Estrogens; Female; Gonadal Steroid Hormones | 2010 |
Neuroinflammation and ageing: current theories and an overview of the data.
Topics: Aging; Alzheimer Disease; Apoptosis; Atherosclerosis; Biological Evolution; Brain; Cellular Senescen | 2011 |
Dehydroepiandrosterone (DHEA)--a precursor steroid or an active hormone in human physiology.
Topics: Aging; Animals; Body Composition; Bone and Bones; Cardiovascular Diseases; Dehydroepiandrosterone; D | 2011 |
Oxidative metabolism of dehydroepiandrosterone (DHEA) and biologically active oxygenated metabolites of DHEA and epiandrosterone (EpiA)--recent reports.
Topics: Androsterone; Animals; Brain; Cardiovascular Diseases; Dehydroepiandrosterone; Female; Humans; Hydro | 2012 |
Recently published papers: inflammation, elucidation, manipulation?
Topics: Biomarkers; Dehydroepiandrosterone; Humans; Hydrocortisone; Inflammation; Respiration, Artificial; S | 2003 |
Therapeutic uses of dehydroepiandrosterone.
Topics: Adrenal Insufficiency; Aging; Animals; Bone Density; Chronic Disease; Dehydroepiandrosterone; Humans | 2003 |
Dehydroepiandrosterone, dehydroepiandrosterone sulfate and related steroids: their role in inflammatory, allergic and immunological disorders.
Topics: Aging; Animals; Anti-Inflammatory Agents; Autoimmune Diseases; Cytokines; Dehydroepiandrosterone; De | 2005 |
Inflammation and sex hormone metabolism.
Topics: Androgens; Animals; Arthritis, Rheumatoid; Dehydroepiandrosterone; Estrogens; Humans; Inflammation; | 2006 |
Potential biomarkers of ageing.
Topics: Aging; Animals; Biomarkers; Cellular Senescence; Dehydroepiandrosterone; Estrogens; Growth Hormone; | 2008 |
DHEA(S): the fountain of youth.
Topics: Aging; Animals; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Humans; Inflammation | 2001 |
7 trials available for dehydroepiandrosterone and Inflammation
| Article | Year |
|---|---|
The effect of glutamine on Dehydroepiandrosterone-induced polycystic ovary syndrome rats.
Topics: Animals; Dehydroepiandrosterone; Female; Glutamine; Humans; Inflammation; Oxidative Stress; Polycyst | 2020 |
A synthetic anti-inflammatory sterol improves insulin sensitivity in insulin-resistant obese impaired glucose tolerance subjects.
Topics: Adiponectin; Adult; Anti-Inflammatory Agents; Blood Glucose; Body Mass Index; C-Reactive Protein; Ch | 2013 |
Hyperandrogenism induces a proinflammatory TNFα response to glucose ingestion in a receptor-dependent fashion.
Topics: Adult; Androstenedione; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Double-Blind Method; | 2014 |
Salivary resistin reflects local inflammation in Sjögren's syndrome.
Topics: Adjuvants, Immunologic; Adult; Aged; Biomarkers; Case-Control Studies; Dehydroepiandrosterone; Femal | 2008 |
A new antidiabetic compound attenuates inflammation and insulin resistance in Zucker diabetic fatty rats.
Topics: Adult; Analysis of Variance; Animals; Blood Glucose; Blotting, Western; Cell Movement; Chemokines; C | 2010 |
Dehydroepiandrosterone (DHEA) replacement decreases insulin resistance and lowers inflammatory cytokines in aging humans.
Topics: Aged; Aging; Animals; Blood Chemical Analysis; Cytokines; Dehydroepiandrosterone; Energy Intake; Exe | 2011 |
Dehydroepiandrosterone in relation to other adrenal hormones during an acute inflammatory stressful disease state compared with chronic inflammatory disease: role of interleukin-6 and tumour necrosis factor.
Topics: Acute Disease; Adrenal Cortex Hormones; Adult; Androstenedione; Cardiac Surgical Procedures; Chronic | 2002 |
56 other studies available for dehydroepiandrosterone and Inflammation
| Article | Year |
|---|---|
Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
Topics: Animals; Biotinylation; Flow Cytometry; Fluorescence Resonance Energy Transfer; Green Fluorescent Pr | 2010 |
Synthesis of 5α-cholestan-6-one derivatives and their inhibitory activities of NO production in activated microglia: discovery of a novel neuroinflammation inhibitor.
Topics: Animals; Cell Line; Cell Survival; Cholestanones; Crystallography, X-Ray; Disease Models, Animal; Do | 2014 |
Stress and the gut-brain axis: Cognitive performance, mood state, and biomarkers of blood-brain barrier and intestinal permeability following severe physical and psychological stress.
Topics: Affect; Biomarkers; Blood-Brain Barrier; Brain-Gut Axis; Cognition; Dehydroepiandrosterone; Epinephr | 2022 |
Ovarian inflammatory mRNA profiles of a dehydroepiandrosterone plus high-fat diet-induced polycystic ovary syndrome mouse model.
Topics: Animals; Dehydroepiandrosterone; Diet, High-Fat; Disease Models, Animal; Female; Humans; Inflammatio | 2022 |
Inhibitory effect of bushen huoxue formula against dehydroepiandrosterone-induced inflammation in granulosa cells through TLR4/NF-κB signaling pathway.
Topics: Androgens; Cytokines; Dehydroepiandrosterone; Drugs, Chinese Herbal; Female; Granulosa Cells; Humans | 2022 |
Baogong decoction treats endometritis in mice by regulating uterine microbiota structure and metabolites.
Topics: Animals; Dehydroepiandrosterone; Endometritis; Escherichia coli; Female; Humans; Inflammation; Mice; | 2022 |
Inhibition of 8-oxoguanine DNA glycosylase (OGG1) expression suppresses polycystic ovarian syndrome via the NF-κB signaling pathway.
Topics: Animals; Benzimidazoles; Dehydroepiandrosterone; DNA Glycosylases; Female; Guanine; Humans; Inflamma | 2022 |
Upregulation of TXNIP contributes to granulosa cell dysfunction in polycystic ovary syndrome via activation of the NLRP3 inflammasome.
Topics: Animals; Carrier Proteins; Dehydroepiandrosterone; Female; Granulosa Cells; Humans; Inflammasomes; I | 2023 |
Upregulation of TXNIP contributes to granulosa cell dysfunction in polycystic ovary syndrome via activation of the NLRP3 inflammasome.
Topics: Animals; Carrier Proteins; Dehydroepiandrosterone; Female; Granulosa Cells; Humans; Inflammasomes; I | 2023 |
Upregulation of TXNIP contributes to granulosa cell dysfunction in polycystic ovary syndrome via activation of the NLRP3 inflammasome.
Topics: Animals; Carrier Proteins; Dehydroepiandrosterone; Female; Granulosa Cells; Humans; Inflammasomes; I | 2023 |
Upregulation of TXNIP contributes to granulosa cell dysfunction in polycystic ovary syndrome via activation of the NLRP3 inflammasome.
Topics: Animals; Carrier Proteins; Dehydroepiandrosterone; Female; Granulosa Cells; Humans; Inflammasomes; I | 2023 |
PDE4 inhibitor Roflumilast modulates inflammation and lipid accumulation in PCOS mice to improve ovarian function and reduce DHEA-induced granulosa cell apoptosis in vitro.
Topics: Animals; Apoptosis; Dehydroepiandrosterone; Female; Granulosa Cells; Humans; Inflammation; Lipids; M | 2023 |
Nerolidol attenuates dehydroepiandrosterone-induced polycystic ovary syndrome in rats by regulating oxidative stress and decreasing apoptosis.
Topics: Animals; Apoptosis; Dehydroepiandrosterone; Disease Models, Animal; Female; Humans; Inflammation; Ox | 2023 |
Effects of a ketogenic diet on reproductive and metabolic phenotypes in mice with polycystic ovary syndrome†.
Topics: Animals; Dehydroepiandrosterone; Diet, Ketogenic; Disease Models, Animal; Female; Humans; Inflammati | 2023 |
Dehydroepiandrosterone protects against oleic acid-triggered mitochondrial dysfunction to relieve oxidative stress and inflammation via activation of the AMPK-Nrf2 axis by targeting GPR30 in hepatocytes.
Topics: AMP-Activated Protein Kinases; Animals; Chickens; Dehydroepiandrosterone; Female; Hepatocytes; Human | 2023 |
Glucagon-like peptide-1 receptor agonists decrease hyperinsulinemia and hyperandrogenemia in dehydroepiandrosterone-induced polycystic ovary syndrome mice and are associated with mitigating inflammation and inducing browning of white adipose tissue†.
Topics: Adipose Tissue, White; Animals; Dehydroepiandrosterone; Female; Glucagon-Like Peptide-1 Receptor; Hu | 2023 |
Exercise-induced irisin improves follicular dysfunction by inhibiting IRE1α-TXNIP/ROS-NLRP3 pathway in PCOS.
Topics: Animals; Carrier Proteins; Cell Cycle Proteins; Dehydroepiandrosterone; Endoribonucleases; Female; F | 2023 |
Hyperandrogenism drives ovarian inflammation and pyroptosis: A possible pathogenesis of PCOS follicular dysplasia.
Topics: Animals; Dehydroepiandrosterone; Female; Humans; Hyperandrogenism; Inflammation; Mice; Polycystic Ov | 2023 |
Dehydroepiandrosterone resisted E. Coli O157:H7-induced inflammation via blocking the activation of p38 MAPK and NF-κB pathways in mice.
Topics: Animals; Cytokines; Dehydroepiandrosterone; Down-Regulation; Escherichia coli; Inflammation; Male; M | 2020 |
γ-Linolenic acid ameliorates DHEA induced pro-inflammatory response in polycystic ovary syndrome via PPAR-γ signaling in rats.
Topics: Animals; Dehydroepiandrosterone; Female; gamma-Linolenic Acid; Gene Expression; Inflammation; Peroxi | 2020 |
Environmental enrichment modulates inflammation during development in long-evans rats (Rattus norvegicus).
Topics: Animals; Cytokines; Dehydroepiandrosterone; Environment; Hypothalamo-Hypophyseal System; Inflammatio | 2021 |
Dehydroepiandrosterone attenuates LPS-induced inflammatory responses via activation of Nrf2 in RAW264.7 macrophages.
Topics: Animals; Anti-Inflammatory Agents; Cell Line; Cytokines; Dehydroepiandrosterone; Inflammation; Infla | 2021 |
Initial systemic inflammatory state perturbs exercise training adaptations in elite Taekwondo athletes.
Topics: Adaptation, Physiological; Athletes; Body Fat Distribution; Dehydroepiandrosterone; Exercise; Female | 2017 |
DHEA inhibits acute microglia-mediated inflammation through activation of the TrkA-Akt1/2-CREB-Jmjd3 pathway.
Topics: Animals; CREB-Binding Protein; Dehydroepiandrosterone; Inflammation; Jumonji Domain-Containing Histo | 2018 |
The secretory phenotype of senescent astrocytes isolated from Wistar newborn rats changes with anti-inflammatory drugs, but does not have a short-term effect on neuronal mitochondrial potential.
Topics: Animals; Animals, Newborn; Anti-Inflammatory Agents; Astrocytes; Cellular Senescence; Central Nervou | 2018 |
Neuroendocrine and inflammatory responses to DHEA administration in young healthy women.
Topics: Dehydroepiandrosterone; Double-Blind Method; Female; Humans; Inflammation; Neurosecretory Systems; S | 2018 |
Dehydroepiandrosterone stimulates inflammation and impairs ovarian functions of polycystic ovary syndrome.
Topics: Animals; Apoptosis; Cell Line; Dehydroepiandrosterone; Disease Models, Animal; Down-Regulation; Fema | 2019 |
Effect of dehydroepiandrosterone on the immune function of mice in vivo and in vitro.
Topics: Animals; Antioxidants; Cytokines; Dehydroepiandrosterone; Inflammation; Lipopolysaccharides; Macroph | 2019 |
Inulin and metformin ameliorate polycystic ovary syndrome via anti-inflammation and modulating gut microbiota in mice.
Topics: Animals; Anti-Inflammatory Agents; Bacteria; Biomarkers; Cytokines; Dehydroepiandrosterone; Diet, Hi | 2019 |
Dehydroepiandrosterone alleviates E. Coli O157:H7-induced inflammation by preventing the activation of p38 MAPK and NF-κB pathways in mice peritoneal macrophages.
Topics: Animals; Anti-Inflammatory Agents; Cytokines; Dehydroepiandrosterone; Escherichia coli; Inflammation | 2019 |
Dehydroepiandrosterone protects endothelial cells against inflammatory events induced by urban particulate matter and titanium dioxide nanoparticles.
Topics: Adjuvants, Immunologic; Cell Adhesion; Cell Proliferation; Coculture Techniques; Dehydroepiandroster | 2013 |
Effect of dehydroepiandrosterone on atopic dermatitis-like skin lesions induced by 1-chloro-2,4-dinitrobenzene in mouse.
Topics: Adjuvants, Immunologic; Animals; Anti-Inflammatory Agents; Chemokines; Cytokines; Dehydroepiandroste | 2013 |
DHEA inhibits vascular remodeling following arterial injury: a possible role in suppression of inflammation and oxidative stress derived from vascular smooth muscle cells.
Topics: Angiotensin II; Animals; Aorta, Thoracic; Carotid Artery Injuries; Cell Movement; Cell Proliferation | 2014 |
Dehydroepiandrosterone modulates the inflammatory response in a bilateral femoral shaft fracture model.
Topics: Adjuvants, Immunologic; Animals; Cytokines; Dehydroepiandrosterone; Disease Models, Animal; Femoral | 2014 |
Induction of hyperandrogenism in lean reproductive-age women stimulates proatherogenic inflammation.
Topics: Adult; Androgens; C-Reactive Protein; Dehydroepiandrosterone; Female; Humans; Hyperandrogenism; Infl | 2015 |
Relation of left ventricular ejection fraction and functional capacity with metabolism and inflammation in chronic heart failure with reduced ejection fraction (from the MIMICA Study).
Topics: Adiponectin; Aged; C-Reactive Protein; Chronic Disease; Dehydroepiandrosterone; Female; Heart Failur | 2010 |
Dehydroepiandrosterone modulates survival and immune functions during sepsis depending on the way of drug administration.
Topics: Animals; Apoptosis; Cell Proliferation; Cytokines; Dehydroepiandrosterone; Disease Models, Animal; D | 2010 |
Protective effects of dehydroepiandrosterone on atherosclerosis in ovariectomized rabbits via alleviating inflammatory injury in endothelial cells.
Topics: Animals; Atherosclerosis; Chemokine CCL2; Dehydroepiandrosterone; E-Selectin; Endothelial Cells; Fem | 2011 |
HE3286, an orally bioavailable synthetic analogue of an active DHEA metabolite suppresses spontaneous autoimmune diabetes in the non-obese diabetic (NOD) mouse.
Topics: Administration, Oral; Animals; Biological Availability; CD4 Antigens; Dehydroepiandrosterone; Diabet | 2011 |
Molecular targets for 17α-ethynyl-5-androstene-3β,7β,17β-triol, an anti-inflammatory agent derived from the human metabolome.
Topics: Adipocytes; Androstenols; Animals; Anti-Inflammatory Agents; Autoimmunity; Cell Line; Dehydroepiandr | 2012 |
Adverse neuro-immune-endocrine interactions in patients with active tuberculosis.
Topics: Cytokines; Dehydroepiandrosterone; Humans; Inflammation; Neuroimmunomodulation; Stress, Psychologica | 2013 |
Cortisol, dehydroepiandrosterone sulfate, and androstenedione levels in patients with polymyalgia rheumatica during twelve months of glucocorticoid therapy.
Topics: Adrenal Cortex; Adrenal Hyperplasia, Congenital; Adrenocorticotropic Hormone; Aged; Aging; Androsten | 2002 |
Dehydroepiandrosterone attenuates allergic airway inflammation in Dermatophagoides farinae-sensitized mice.
Topics: Animals; Antigens, Dermatophagoides; Bronchial Hyperreactivity; Dehydroepiandrosterone; Female; Immu | 2002 |
Steroid hormone profile of canine inflammatory mammary carcinoma: a preliminary study.
Topics: Androstenedione; Animals; Carcinoma; Dehydroepiandrosterone; Dogs; Estradiol; Estrone; Female; Immun | 2003 |
Adrenocortical hormones in survivors and nonsurvivors of severe sepsis: diverse time course of dehydroepiandrosterone, dehydroepiandrosterone-sulfate, and cortisol.
Topics: Adrenocorticotropic Hormone; Age Factors; Aged; APACHE; C-Reactive Protein; Calcitonin; Dehydroepian | 2003 |
[Comparative study of local changes in connective tissue induced by testosterone propionate, dehydroepiandrosterone, methylandrostenediol and cholesterol].
Topics: Androgens; Cholesterol; Connective Tissue; Dehydroepiandrosterone; Inflammation; Methandriol; Testos | 1956 |
Dehydroepiandrosterone modulates toll-like receptor expression on splenic macrophages of mice after severe polymicrobial sepsis.
Topics: Adjuvants, Immunologic; Animals; Anti-Inflammatory Agents; Cell Membrane; Dehydroepiandrosterone; DN | 2005 |
Androgen conversion in osteoarthritis and rheumatoid arthritis synoviocytes--androstenedione and testosterone inhibit estrogen formation and favor production of more potent 5alpha-reduced androgens.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Androgens; Androstenedione; Aromatase; Arthritis, Rheumatoid; | 2005 |
Increase in glucose-6-phosphate dehydrogenase in adipocytes stimulates oxidative stress and inflammatory signals.
Topics: 3T3 Cells; Adipocytes; Adipose Tissue; Animals; Dehydroepiandrosterone; Gene Expression Regulation; | 2006 |
Regulation of macrophage dehydroepiandrosterone sulfate metabolism by inflammatory cytokines.
Topics: Animals; Bone Marrow; Bone Marrow Cells; Cells, Cultured; Cytokines; Dehydroepiandrosterone; Dehydro | 1994 |
The etiology of rheumatoid arthritis.
Topics: Adrenal Cortex; Arthritis, Rheumatoid; Cartilage, Articular; Dehydroepiandrosterone; Humans; Hydroco | 1998 |
Immunological properties of dehydroepiandrosterone, its conjugates, and metabolites.
Topics: Adjuvants, Immunologic; Animals; Anti-Inflammatory Agents; Dehydroepiandrosterone; Dexamethasone; Di | 1999 |
Adrenocorticotropin, glucocorticoid, and androgen secretion in patients with new onset synovitis/rheumatoid arthritis: relations with indices of inflammation.
Topics: Adrenocorticotropic Hormone; Adult; Androgens; Arthritis, Rheumatoid; Blood Sedimentation; C-Reactiv | 2000 |
Suppression of 12-O-tetradecanoylphorbol-13-acetate-induced epidermal hyperplasia and inflammation by the dehydroepiandrosterone analog 16alpha-fluoro-5-androsten-17-one and its reversal by NADPH liposomes.
Topics: Androstenes; Animals; Antineoplastic Agents; Binding, Competitive; Capillary Permeability; Carcinoge | 2001 |
Hidradenitis suppurativa: evidence for an endocrine abnormality.
Topics: Adult; Dehydroepiandrosterone; Estradiol; Female; Gonadotropins; Humans; Inflammation; Progesterone; | 1985 |
Mediation of hidradenitis suppurativa by androgens.
Topics: Adolescent; Adult; Androgens; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Estradiol; Fem | 1986 |
[Function of the ovaries and adrenal glands in aseptic inflammation of the ovaries (experimental data)].
Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adrenal Glands; Animals; Dehydroepiandrosterone; Estrus; | 1969 |
Dehydroepiandrosterone (3 -hydroxy-5-androsten-17-one) metabolism in gout.
Topics: 17-Ketosteroids; Administration, Oral; Androstanes; Androsterone; Carbon Isotopes; Chromatography, G | 1972 |
Anti-inflammatory effects of estradiol on human blood leukocytes.
Topics: Acid Phosphatase; Carbon Isotopes; Culture Media; Dehydroepiandrosterone; Diethylstilbestrol; Estrad | 1972 |